Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven O'Reilly

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Clinical Science (London, England : 1979)|November 14, 2013
Innate immunity in systemic sclerosis pathogenesisSteven O'Reilly
Autoimmunity|September 4, 2015
miRNA-29a in systemic sclerosis: A valid targetSteven O'Reilly
Clinical Science (London, England : 1979)|November 14, 2014
Pound the alarm: danger signals in rheumatic diseasesSteven O'Reilly
Rheumatology (Oxford, England)|July 21, 2022
Toll-like receptor triggering in systemic sclerosis: time to targetSteven O'Reilly
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2024
Emerging therapeutic targets in systemic sclerosisSteven O'Reilly
Arthritis Research & Therapy|January 15, 2016
MicroRNAs in fibrosis: opportunities and challengesSteven O'Reilly
Molecular Aspects of Medicine|October 11, 2016
Epigenetics in fibrosisSteven O'Reilly
Annals of the Rheumatic Diseases|February 7, 2023
At the crossroads of inflammation and fibrosis: epiregulinSteven O'Reilly
Experimental Dermatology|September 8, 2015
TETanizing fibrosisSteven O'Reilly
Acta Pharmacologica Sinica|August 12, 2021
Keeping time on liver fibrosisSteven O'Reilly
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Clinical Science (London, England : 1979)|November 14, 2013
Innate immunity in systemic sclerosis pathogenesisSteven O'Reilly
Autoimmunity|September 4, 2015
miRNA-29a in systemic sclerosis: A valid targetSteven O'Reilly
Clinical Science (London, England : 1979)|November 14, 2014
Pound the alarm: danger signals in rheumatic diseasesSteven O'Reilly
Rheumatology (Oxford, England)|July 21, 2022
Toll-like receptor triggering in systemic sclerosis: time to targetSteven O'Reilly
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2024
Emerging therapeutic targets in systemic sclerosisSteven O'Reilly
Arthritis Research & Therapy|January 15, 2016
MicroRNAs in fibrosis: opportunities and challengesSteven O'Reilly
Molecular Aspects of Medicine|October 11, 2016
Epigenetics in fibrosisSteven O'Reilly
Annals of the Rheumatic Diseases|February 7, 2023
At the crossroads of inflammation and fibrosis: epiregulinSteven O'Reilly
Experimental Dermatology|September 8, 2015
TETanizing fibrosisSteven O'Reilly
Acta Pharmacologica Sinica|August 12, 2021
Keeping time on liver fibrosisSteven O'Reilly
Pageof 9